Some Hashimoto's patients, particularly those with significantly compromised thyroid function, persistent untreated insulin resistance, or cortisol dysregulation, may experience less dramatic results
other glucose-lowering drugs in type 2 diabetes: a systematic review and meta-analysis of real-world studies
Noom, Calibrate, and Embla say there is preliminary data to support their contention that many people can maintain weight loss through exercise and diet after stopping the medications (though some of the doctors Fortune spoke with were skeptical of those studies)
The World Anti-Doping Agency is collecting evidence of athletes using the GLP-1 weight loss drugs for a competitive advantage and could ban them before the 2028 Olympics in Los Angeles
Some companies are beginning to cover for other conditions, including obesity, heart disease, obesity with sleep apnea or obesity with high blood pressure